Fig. 5: Distribution of risk groups according to different classification and prognostic tools for treated versus untreated patients. | Leukemia

Fig. 5: Distribution of risk groups according to different classification and prognostic tools for treated versus untreated patients.

From: Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification—an approach to classification of patients with t-MDS

Fig. 5

a Comparison of IPSS-R risk-groups between treated and untreated patients. b Comparison of IPSS-R cytogenetic risk-groups between treated and untreated patients. c Comparison of WHO subgroups between treated and untreated patients.

Back to article page